Thermo Fisher Scientific Inc. (TMO) To Go Ex-Dividend on March 13th

Thermo Fisher Scientific Inc. (NYSE:TMO) declared a quarterly dividend on Wednesday, February 25th. Shareholders of record on Friday, March 13th will be given a dividend of 0.47 per share by the medical research company on Wednesday, April 15th. This represents a c) annualized dividend and a yield of 0.4%. The ex-dividend date of this dividend is Friday, March 13th. This is a 9.3% increase from Thermo Fisher Scientific’s previous quarterly dividend of $0.43.

Thermo Fisher Scientific has raised its dividend by an average of 0.1%per year over the last three years and has raised its dividend every year for the last 8 years. Thermo Fisher Scientific has a payout ratio of 7.0% meaning its dividend is sufficiently covered by earnings. Equities analysts expect Thermo Fisher Scientific to earn $25.56 per share next year, which means the company should continue to be able to cover its $1.72 annual dividend with an expected future payout ratio of 6.7%.

Thermo Fisher Scientific Trading Up 1.2%

Shares of TMO opened at $519.70 on Friday. Thermo Fisher Scientific has a 1 year low of $385.46 and a 1 year high of $643.99. The company has a 50 day simple moving average of $575.17 and a two-hundred day simple moving average of $547.05. The company has a debt-to-equity ratio of 0.67, a current ratio of 1.89 and a quick ratio of 1.53. The firm has a market cap of $195.26 billion, a P/E ratio of 29.30, a price-to-earnings-growth ratio of 2.96 and a beta of 0.93.

Thermo Fisher Scientific (NYSE:TMO) last posted its earnings results on Thursday, January 29th. The medical research company reported $6.57 EPS for the quarter, topping analysts’ consensus estimates of $6.45 by $0.12. The company had revenue of $12.22 billion for the quarter, compared to the consensus estimate of $11.95 billion. Thermo Fisher Scientific had a return on equity of 16.92% and a net margin of 15.05%.The firm’s revenue for the quarter was up 7.2% on a year-over-year basis. During the same period in the previous year, the business earned $6.10 earnings per share. On average, equities analysts expect that Thermo Fisher Scientific will post 23.28 earnings per share for the current fiscal year.

Thermo Fisher Scientific declared that its board has approved a share repurchase plan on Thursday, November 6th that permits the company to buyback $5.00 billion in shares. This buyback authorization permits the medical research company to purchase up to 2.4% of its stock through open market purchases. Stock buyback plans are often a sign that the company’s board believes its shares are undervalued.

About Thermo Fisher Scientific

Thermo Fisher Scientific (NYSE: TMO) is a global provider of scientific instrumentation, reagents and consumables, software, and services that support research, clinical, and industrial laboratories. The company supplies analytical instruments and laboratory equipment, life sciences reagents and kits, specialty diagnostics, and a broad range of consumables used by researchers, clinicians, and manufacturers. Its offerings also include laboratory information management and data-analysis software, as well as service solutions such as instrument maintenance, validation, and logistics that help customers run complex workflows efficiently.

Thermo Fisher operates through multiple business areas that broadly cover life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, including contract development and manufacturing for pharmaceutical and biotechnology companies.